0001855644 2026-10-26 2026-10-26 0001855644 1 2026-10-26 2026-10-26 0001855644 2 2026-10-26 2026-10-26 0001855644 3 2026-10-26 2026-10-26 0001855644 4 2026-10-26 2026-10-26 0001855644 5 2026-10-26 2026-10-26 0001855644 6 2026-10-26 2026-10-26 0001855644 1 2026-10-26 2026-10-26 0001855644 2 2026-10-26 2026-10-26 iso4217:USD pure S-3 S-3 EX-FILING FEES 0001855644 Zura Bio Ltd N/A 0.000087 0.000087 0.000087 0.000087 0.000087 true false S-3 Zura Bio Ltd Equity Class A Ordinary Shares, $0.0001 par value per share true Equity Preference Shares, $0.0001 par value per share true Debt Debt Securities true Other Warrants true Other Units true false Unallocated (Universal) Shelf true 700000000.00 0.000087 60900.00 700000000.00 60900.00 0.00 21446.54 39453.46 There are being registered hereunder such indeterminate number of Class A Ordinary Shares, such indeterminate number of Preference Shares, such indeterminate principal amount of debt securities and such indeterminate number of warrants to purchase Class A Ordinary Shares, Preference Shares and/or debt securities as may be sold from time to time by the Registrant, which collectively shall have a maximum aggregate offering price not to exceed $700,000,000. Any securities registered hereunder may be sold separately or in combination with other securities registered hereunder. The $700,000,000 of securities registered hereunder includes $114,044,900 of Class A Ordinary Shares that may be offered, issued and sold pursuant to that certain Sales Agreement, dated September 3, 2024 by and between the Registrant and Leerink Partners LLC (as amended on October 27, 2026). The securities registered hereunder also include such indeterminate number of Class A Ordinary Shares and Preference Shares and such indeterminate principal amount of debt securities as may be issued upon conversion or exchange of debt securities that provide for conversion or exchange, upon exercise of warrants or pursuant to the antidilution provisions of any such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), the shares being registered hereunder include such indeterminate number of Class A Ordinary Shares and Preference Shares as may be issuable with respect to the shares being registered hereunder as a result of share splits, share dividends or similar transactions. The proposed maximum offering price per unit and maximum aggregate offering price per class of securities will be determined from time to time by the Registrant in connection with the issuance by the Registrant of the securities registered hereunder and are not specified as to each class of security pursuant to General Instruction I.D. and Instruction 2.A.iii.c. to the Calculation of Filing Fee Tables and Related Disclosure under Item 16(b) of Form S-3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable upon exercise, conversion or exchange of other securities. The registration fee is calculated in accordance with Rule 457(o) under the Securities Act based on the proposed maximum aggregate offering price of $700,000,000 of securities that may be issued and sold from time to time under the prospectus contained in this registration statement. true Zura Bio Ltd S-3 333-281905 2024-09-03 21446.54 Equity Class A Ordinary Shares, $0.0001 par value per share 145301800.00 true Zura Bio Ltd S-3 333-281905 2024-09-03 21446.54 The Registrant previously registered $300,000,000 of an indeterminate amount of securities to be offered from time to time at prices to be determined at the time of each such offering pursuant to a Registration Statement on Form S-3 (File No. 333-281905) filed with the Securities and Exchange Commission (the "SEC"), on September 3, 2024, and declared effective by the SEC on September 17, 2024 (the "Prior Registration Statement"). The Registrant previously paid an aggregate registration fee of $44,280 in connection with the Prior Registration Statement (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). As of the date of filing of this Registration Statement, the Registrant has sold an aggregate of $154,698,200 of such securities under the Prior Registration Statement, leaving a balance of $145,301,800 (the "Unsold Securities"), representing $21,446.54 in registration fees attributable to such Unsold Securities under the Prior Registration Statement. Pursuant to Rule 457(p) under the Securities Act, such unutilized filing fees may be applied to the filing fees payable pursuant to this Registration Statement. All offerings under the Prior Registration Statement have terminated. The Registrant previously registered $300,000,000 of an indeterminate amount of securities to be offered from time to time at prices to be determined at the time of each such offering pursuant to the Prior Registration Statement. The Registrant previously paid an aggregate registration fee of $44,280 in connection with the Prior Registration Statement (based on the filing fee rate in effect at the time of the filing of the Prior Registration Statement). As of the date of filing of this Registration Statement, the Registrant sold an aggregate of $154,698,200 of such securities under the Prior Registration Statement, leaving a balance of $145,301,800, representing $21,446.54 in registration fees attributable to such Unsold Securities under the Prior Registration Statement. Pursuant to Rule 457(p) under the Securities Act, such unutilized filing fees may be applied to the filing fees payable pursuant to this Registration Statement. All offerings under the Prior Registration Statement have terminated.